Trials / Completed
CompletedNCT05341687
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in Patients With COVID-19 Associated Acute Respiratory Distress Syndrome (CARDS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 122 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Mortality of patients with COVID-19 associated acute respiratory distress syndrome (CARDS) treated with veno-venous extra-corporal membrane oxygenation (vv-ECMO) is increasing over time since the beginning of the COVID-19 pandemic. The objectives were to retrospectively describe over the first ten days after vv-ECMO implantation, the ventilatory management of CARDS and to assess the impact of static respiratory system compliance (CRS) on the first day of vv-ECMO on 180-day mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No applicable | No applicable |
Timeline
- Start date
- 2020-01-03
- Primary completion
- 2021-12-31
- Completion
- 2023-05-01
- First posted
- 2022-04-22
- Last updated
- 2024-07-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05341687. Inclusion in this directory is not an endorsement.